(Q40321264)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

19 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifen (English)

1 reference

19 September 2017

1 reference

Selina Glaros

1

1 reference

19 September 2017

Natasha Atanaskova

2

1 reference

19 September 2017

Changqing Zhao

3

1 reference

19 September 2017

Debra F Skafar

4

1 reference

19 September 2017

Kaladhar B Reddy

5

1 reference

19 September 2017

publication date

2 February 2006

1 reference

19 September 2017

published in

Molecular Endocrinology

1 reference

19 September 2017

volume

20

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

996-1008

1 reference

AKT activation predicts outcome in breast cancer patients treated with tamoxifen

19 September 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Nuclear receptors enhance our understanding of transcription regulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Functional domains of the human estrogen receptor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Tumor-associated growth factors in malignant rodent and human mammary epithelial cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Phosphorylation of serine-167 on the human oestrogen receptor is important for oestrogen response element binding and transcriptional activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Molecular determinants for the tissue specificity of SERMs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

The steroid and thyroid hormone receptor superfamily

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Dysregulated expression of growth factors and their receptors in the development of prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Akt kinases in breast cancer and the results of adjuvant therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Endocrine-responsive breast cancer and strategies for combating resistance

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Characterization of ligand-dependent phosphorylation of the estrogen receptor.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

The significance of heregulin in breast cancer tumor progression and drug resistance

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Full Activation of Estrogen Receptor α Activation Function-1 Induces Proliferation of Breast Cancer Cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

The nuclear hormone receptor gene superfamily

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Transformation of mammalian cells by constitutively active MAP kinase kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Characterization of the Amino-terminal Transcriptional Activation Function of the Human Estrogen Receptor in Animal and Yeast Cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1210/ME.2005-0285

Identifiers

DOI

10.1210/ME.2005-0285

1 reference

19 September 2017

1 reference